Jenny Berg

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: VALUE IN HEALTH. 2023;26(5):639-648
Economic Evaluation of Elective Cesarean Section on Maternal Request Compared With Planned Vaginal Birth-Application to Swedish Setting Using National Registry Data
Berg J; Kallen K; Andolf E; Hellstrom-Westas L; Ekeus C; Alvan J; Vitols S
Article: QUALITY OF LIFE RESEARCH. 2022;31(7):2133-2142
'Like holding the axe on who should live or not': adolescents' and adults' perceptions of valuing children's health states using a standardised valuation protocol for the EQ-5D-Y-3L
Astrom M; Conte H; Berg J; Burstrom K
Article: JOURNAL OF CLINICAL MEDICINE. 2021;10(18):4205
Concordance among Swedish, German, Danish, and UK EQ-5D-3L Value Sets: Analyses of Patient-Reported Outcomes in the Swedish Hip Arthroplasty Register
Teni FS; Rolfson O; Berg J; Leidl R; Burstrom K
Article: BMC MUSCULOSKELETAL DISORDERS. 2020;21(1):441
Predictive ability of the American Society of Anaesthesiologists physical status classification system on health-related quality of life of patients after total hip replacement: comparisons across eight EQ-5D-3L value sets
Teni FS; Burstrom K; Berg J; Leidl R; Rolfson O
Article: VALUE IN HEALTH. 2019;22(2):231-238
Association between Disability, Cognition, Fatigue, EQ-5D-3L Domains, and Utilities Estimated with Different Western European Value Sets in Patients with Multiple Sclerosis.
Eriksson J; Kobelt G; Gannedahl M; Berg J
Article: EUROPACE. 2018;20(6):929-934
The influence of progression of atrial fibrillation on quality of life: a report from the Euro Heart Survey
Dudink EAMP; Erkuner O; Berg J; Nieuwlaat R; de Vos CB; Weijs B; Capucci A; Camm AJ; Breithardt G; Le Heuzey J-Y; Luermans JGLM; Crijns HJGM
Article: MULTIPLE SCLEROSIS JOURNAL. 2017;23(2_suppl):179-191
New insights into the burden and costs of multiple sclerosis in Europe: Results for Sweden
Brundin L; Kobelt G; Berg J; Capsa D; Eriksson J
Article: MULTIPLE SCLEROSIS JOURNAL. 2017;23(2_suppl):104-116
New insights into the burden and costs of multiple sclerosis in Europe: Results for Italy.
Battaglia M; Kobelt G; Ponzio M; Berg J; Capsa D; Dalén J; European Multiple Sclerosis Platform
Article: MULTIPLE SCLEROSIS JOURNAL. 2017;23(2_suppl):17-28
New insights into the burden and costs of multiple sclerosis in Europe: Results for Austria.
Berger T; Kobelt G; Berg J; Capsa D; Gannedahl M; European Multiple Sclerosis Platform
Article: MULTIPLE SCLEROSIS JOURNAL. 2017;23(2_suppl):29-40
New insights into the burden and costs of multiple sclerosis in Europe: Results for Belgium.
Dubois B; Kobelt G; Berg J; Capsa D; Gannedahl M; European Multiple Sclerosis Platform
Article: MULTIPLE SCLEROSIS JOURNAL. 2017;23(2_suppl):166-178
New insights into the burden and costs of multiple sclerosis in Europe: Results for Spain.
Oreja-Guevara C; Kobelt G; Berg J; Capsa D; Eriksson J; European Multiple Sclerosis Platform
Article: MULTIPLE SCLEROSIS JOURNAL. 2017;23(2_suppl):192-203
New insights into the burden and costs of multiple sclerosis in Europe: Results for Switzerland.
Calabrese P; Kobelt G; Berg J; Capsa D; Eriksson J; European Multiple Sclerosis Platform
Article: MULTIPLE SCLEROSIS JOURNAL. 2017;23(2_suppl):117-129
New insights into the burden and costs of multiple sclerosis in Europe: Results for the Netherlands.
Uitdehaag B; Kobelt G; Berg J; Capsa D; Dalén J; European Multiple Sclerosis Platform
Article: MULTIPLE SCLEROSIS JOURNAL. 2017;23(2_suppl):78-90
New insights into the burden and costs of multiple sclerosis in Europe: Results for Germany.
Flachenecker P; Kobelt G; Berg J; Capsa D; Gannedahl M; European Multiple Sclerosis Platform
Article: MULTIPLE SCLEROSIS JOURNAL. 2017;23(2_suppl):4-16
The burden of multiple sclerosis 2015: Methods of data collection, assessment and analysis of costs, quality of life and symptoms.
Kobelt G; Eriksson J; Phillips G; Berg J
Article: MULTIPLE SCLEROSIS JOURNAL. 2017;23(2_suppl):91-103
New insights into the burden and costs of multiple sclerosis in Europe: Results for Hungary.
Péntek M; Kobelt G; Berg J; Capsa D; Dalén J; Bíró Z; Mátyás K; Komoly S; European Multiple Sclerosis Platform
Article: MULTIPLE SCLEROSIS JOURNAL. 2017;23(2_suppl):155-165
New insights into the burden and costs of multiple sclerosis in Europe: Results for Russia.
Boyko A; Kobelt G; Berg J; Boyko O; Popova E; Capsa D; Eriksson J; European Multiple Sclerosis Platform
Article: MULTIPLE SCLEROSIS JOURNAL. 2017;23(2_suppl):53-64
New insights into the burden and costs of multiple sclerosis in Europe: Results for Denmark.
Rasmussen PV; Kobelt G; Berg J; Capsa D; Gannedahl M; European Multiple Sclerosis Platform
Article: MULTIPLE SCLEROSIS JOURNAL. 2017;23(2_suppl):65-77
New insights into the burden and costs of multiple sclerosis in Europe: Results for France.
Lebrun-Frenay C; Kobelt G; Berg J; Capsa D; Gannedahl M; European Multiple Sclerosis Platform
Article: MULTIPLE SCLEROSIS JOURNAL. 2017;23(2_suppl):204-216
New insights into the burden and costs of multiple sclerosis in Europe: Results for the United Kingdom.
Thompson A; Kobelt G; Berg J; Capsa D; Eriksson J; Miller D; European Multiple Sclerosis Platform
Article: MULTIPLE SCLEROSIS JOURNAL. 2017;23(2_suppl):130-142
New insights into the burden and costs of multiple sclerosis in Europe: Results for Poland.
Selmaj K; Kobelt G; Berg J; Orlewska E; Capsa D; Dalén J; European Multiple Sclerosis Platform
Article: MULTIPLE SCLEROSIS JOURNAL. 2017;23(2_suppl):143-154
New insights into the burden and costs of multiple sclerosis in Europe: Results for Portugal.
Sá MJ; Kobelt G; Berg J; Capsa D; Dalén J; European Multiple Sclerosis Platform
Article: MULTIPLE SCLEROSIS JOURNAL. 2017;23(2_suppl):41-52
New insights into the burden and costs of multiple sclerosis in Europe: Results of the Czech Republic.
Havrdova E; Kobelt G; Berg J; Capsa D; Gannedahl M; Doležal T; European Multiple Sclerosis Platform
Article: MULTIPLE SCLEROSIS JOURNAL. 2017;23(8):1123-1136
New insights into the burden and costs of multiple sclerosis in Europe.
Kobelt G; Thompson A; Berg J; Gannedahl M; Eriksson J; MSCOI Study Group; European Multiple Sclerosis Platform
Article: VALUE IN HEALTH. 2015;18(4):439-448
Determinants of Utility Based on the EuroQol Five-Dimensional Questionnaire in Patients with Chronic Heart Failure and Their Change Over Time: Results from the Swedish Heart Failure Registry
Berg J; Lindgren P; Mejhert M; Edner M; Dahlstrom U; Kahan T
Article: BMC HEALTH SERVICES RESEARCH. 2014;14:246
Demographics, clinical characteristics, health resource utilization and cost of chronic thromboembolic pulmonary hypertension patients: retrospective results from six European countries.
Schweikert B; Pittrow D; Vizza CD; Pepke-Zaba J; Hoeper MM; Gabriel A; Berg J; Sikirica M
Article: JRSM CARDIOVASCULAR DISEASE. 2014;3:2048004014548735
Health-related quality of life and long-term morbidity and mortality in patients hospitalised with systolic heart failure
Berg J; Lindgren P; Kahan T; Schill O; Persson H; Edner M; Mejhert M
Article: CANADIAN JOURNAL OF CARDIOLOGY. 2013;29(10):1249-1255
Cost-Effectiveness of Dronedarone in Patients With Atrial Fibrillation in the ATHENA Trial
Berg J; Sauriol L; Connolly S; Lindgren P
Article: DIABETES THERAPY. 2013;4(2):363-374
Annual Medical Costs of Swedish Patients with Type 2 Diabetes Before and After Insulin Initiation
Bexelius C; Lundberg J; Wang X; Berg J; Hjelm H
Article: QUALITY OF LIFE RESEARCH. 2010;19(3):381-390
Factors determining utility measured with the EQ-5D in patients with atrial fibrillation
Berg J; Lindgren P; Nieuwlaat R; Bouin O; Crijns H
Article: ALLERGY. 2009;64(3):431-438
An economic evaluation of NIOX MINO airway inflammation monitor in the United Kingdom
Price D; Berg J; Lindgren P
Article: MULTIPLE SCLEROSIS JOURNAL. 2008;14(5):679-690
Modeling the cost-effectiveness of a new treatment for MS (natalizumab) compared with current standard practice in Sweden
Kobelt G; Berg J; Lindgren P; Jonsson B; Stawiarz L; Hillert J
Article: RESPIRATORY MEDICINE. 2008;102(2):219-231
Economic evaluation of FE_NO measurement in diagnosis and 1-year management of asthma in Germany
Berg J; Lindgren P
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2007;22(7):649-655
Health utilities in mild cognitive impairment and dementia:: a population study in Sweden
Ekman M; Berg J; Wimo A; Jonsson L; McBurney C
Article: CLINICAL THERAPEUTICS. 2007;29(6):1184-1202
Cost-effectiveness of clopidogrel in myocardial infarction with ST-segment elevation:: A European model based on the CLARITY and COMMIT trials
Berg J; Lindgren P; Spiesser J; Parry D; Jonsson B
Article: ACTA PAEDIATRICA. 2006;95(12):1550-1555
Preterm birth in Sweden:: What are the average lengths of hospital stay and the associated inpatient costs?
Ringborg A; Berg J; Norman M; Westgren M; Jonsson B
Article: EUROPEAN JOURNAL OF HEALTH ECONOMICS. 2006;7 Suppl 2:5-13
Costs and quality of life in multiple sclerosis in Europe: method of assessment and analysis.
Kobelt G; Berg J; Lindgren P; Jönsson B
Article: EUROPEAN JOURNAL OF HEALTH ECONOMICS. 2006;7 Suppl 2:55-64
Costs and quality of life in multiple sclerosis in The Netherlands.
Kobelt G; Berg J; Lindgren P; Anten B; Ekman M; Jongen PJH; Polman C; Uitdehaag B
Article: EUROPEAN JOURNAL OF HEALTH ECONOMICS. 2006;7 Suppl 2:75-85
Costs and quality of life of multiple sclerosis in Sweden.
Berg J; Lindgren P; Fredrikson S; Kobelt G
Article: EUROPEAN JOURNAL OF HEALTH ECONOMICS. 2006;7 Suppl 2:96-104
Costs and quality of life of multiple sclerosis in the United Kingdom.
Kobelt G; Berg J; Lindgren P; Kerrigan J; Russell N; Nixon R
Article: EUROPEAN JOURNAL OF HEALTH ECONOMICS. 2006;7 Suppl 2:65-74
Costs and quality of life of multiple sclerosis in Spain.
Kobelt G; Berg J; Lindgren P; Izquierdo G; Sánchez-Soliño O; Pérez-Miranda J; Casado MA; Associación Española de Esclerosis Múltiple
Article: EUROPEAN JOURNAL OF HEALTH ECONOMICS. 2006;7 Suppl 2:14-23
Costs and quality of life of multiple sclerosis in Austria.
Kobelt G; Berg J; Lindgren P; Plesnilla C; Baumhackl U; Berger T; Kolleger H; Vass K
Article: EUROPEAN JOURNAL OF HEALTH ECONOMICS. 2006;7 Suppl 2:86-95
Costs and quality of life of multiple sclerosis in Switzerland.
Kobelt G; Berg J; Lindgren P; Gerfin A; Lutz J
Article: EUROPEAN JOURNAL OF HEALTH ECONOMICS. 2006;7 Suppl 2:34-44
Costs and quality of life of multiple sclerosis in Germany.
Kobelt G; Berg J; Lindgren P; Elias WG; Flachenecker P; Freidel M; König N; Limmroth V; Straube E
Article: EUROPEAN JOURNAL OF HEALTH ECONOMICS. 2006;7 Suppl 2:45-54
Costs and quality of life of multiple sclerosis in Italy.
Kobelt G; Berg J; Lindgren P; Battaglia M; Lucioni C; Uccelli A
Article: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2006;77(8):918-926
Costs and quality of life of patients with multiple sclerosis in Europe
Kobelt G; Berg J; Lindgren P; Fredrikson S; Jonsson B
Article: NEUROLOGY. 2006;66(11):1696-1702
Costs and quality of life in multiple sclerosis - A cross-sectional study in the United States
Kobelt G; Berg J; Atherly D; Hadjimichael O
Article: EUROPEAN JOURNAL OF NEUROLOGY. 2005;12 Suppl 1:85-90
Cost of trauma in Europe.
Berg J; Tagliaferri F; Servadei F
Article: EUROPEAN JOURNAL OF NEUROLOGY. 2005;12 Suppl 1:59-62
Cost of migraine and other headaches in Europe.
Berg J; Stovner LJ
Visa fler

Alla övriga publikationer

Review: BMC PSYCHIATRY. 2023;23(1):952
Relational continuity may give better clinical outcomes in patients with serious mental illness - a systematic review.
Engström I; Hansson L; Ali L; Berg J; Ekstedt M; Engström S; Fredriksson MK; Liliemark J; Lytsy P
Review: QUALITY OF LIFE RESEARCH. 2023;32(10):2719-2729
Use of the visual analogue scale for health state valuation: a scoping review
Astrom M; Lwin ZMT; Teni FS; Burstrom K; Berg J
Review: ECLINICALMEDICINE. 2022;49:101492
Outcomes associated with higher relational continuity in the treatment of persons with asthma or chronic obstructive pulmonary disease: A systematic review
Lytsy P; Engstrom S; Ekstedt M; Engstrom I; Hansson L; Ali L; Fredriksson MK; Liliemark J; Berg J
Review: LAKARTIDNINGEN. 2020;117:20016
[Traumatic brain injury rehabilitation - assessment of quantitative and qualitative research].
Wilbe Ramsay K; Berg J; Bunketorp Käll L; Lexell J; Larsson Lund M; Möller M; Stenberg M; Strandberg T
Meeting abstract: VALUE IN HEALTH. 2009;12(3):A176
ECONOMIC EVALUATION OF AGOMELATINE FOR MAJOR DEPRESSIVE DISORDER IN SWEDEN
Clapham E; Berg J; Ekman M; Jonsson L
Meeting abstract: VALUE IN HEALTH. 2008;11(6):A423-A424
COST OF INSOMNIA IN PATIENTS OVER 54YEARS IN SWEDEN
Justo N; Jonsson L; Ekman M; Berg J
Meeting abstract: VALUE IN HEALTH. 2008;11(6):A410
FACTORS DETERMINING UTILITY MEASURED WITH THE EQ-5D IN PATIENTS WITH ATRIAL FIBRILLATION
Berg J; Lindgren P; Nieuwlaat R; Bascle S; Crijns H
Published conference paper: CURRENT MEDICAL RESEARCH AND OPINION. 2008;24(7):2089-2101
Cost-effectiveness of clopidogrel treatment in percutaneous coronary intervention: a European model based on a meta-analysis of the PCI-CURE, CREDO and PCI-CLARITY trials
Berg J; Fidan D; Lindgren P
Meeting abstract: VALUE IN HEALTH. 2007;10(6):A414
Cost-effectiveness of clopidogrel in myocardial infarction with ST-segment elevation - A European model based on the clarity and commit trials: Adaptation to Hungary
Berg J; Odhiambo R; Lindgren P
Meeting abstract: VALUE IN HEALTH. 2007;10(6):A239-A240
Modeling the cost-effectiveness of a new treatment for MS (natalizumab) compared to current standard practice in Sweden
Kobelt G; Berg J; Lindgren P; Hillert J
Corrigendum: EUROPEAN JOURNAL OF HEALTH ECONOMICS. 2007;8(4):359
Costs and quality of life in multiple sclerosis in The Netherlands (vol 7, pg S55, 2006)
Kobelt G; Berg J; Lindgren P; Anten B; Ekman M; Jongen PJH; Polman C; Uitdehaag B
Meeting abstract: VALUE IN HEALTH. 2007;10(3):A110
Economic evaluation of a new airway inflammation monitor in the diagnosis and management of asthma in the US
Berg J; Lindgren P
Meeting abstract: VALUE IN HEALTH. 2006;9(6):A346-A347
Cost-effectiveness of clopidogrel in myocardial infarction with ST-segment elevation:: European model results based on clarity and commit
Berg J; Lindgren P; Jonsson B
Meeting abstract: VALUE IN HEALTH. 2006;9(6):A333
Economic evaluation of a new airway inflammation monitor in the diagnosis and management of asthma in Germany
Berg J; Lindgren P; Joensson B
Meeting abstract: VALUE IN HEALTH. 2005;8(6):A134
The cost of multiple sclerosis (MS) in Europe
Berg J; Kobelt G; Lindgren P; Fredrikson S; Jönsson B
Review: EUROPEAN JOURNAL OF HEALTH ECONOMICS. 2004;5 Suppl 1:s84-s91
Economic evidence in trauma: a review.
Berg J
Review: EUROPEAN JOURNAL OF HEALTH ECONOMICS. 2004;5 Suppl 1:s43-s54
Economic evidence in migraine and other headaches: a review.
Berg J

Anställningar

Anknuten till Forskning, Lärande, Informatik, Management och Etik, Karolinska Institutet, 2025-2025

Examina och utbildning

Medicine Doktorsexamen, Institutet för miljömedicin, Karolinska Institutet, 2015

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI